Management of pharmacological treatment in patients with COPD and the direct cost of long-term anticholinergic therapy: real-word experience
Objective: To describe the experience with the use of long-term anticholinergic therapy available in the public service. Method: A cross-sectional study with data collected in the real world. The sample consisted of SUS users who received inhaled LAMAs for the treatment of COPD between November 2019...
Saved in:
Main Authors: | Isabelle V. BORGES (Author), Priscilla A. ROCHA (Author), Karen R. PALERMO (Author), Andrea P. SFORSIN (Author), Vanusa B. PINTO (Author), Rafael STELMACH (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Universal Pharmacological-Based List of Drugs with Anticholinergic Activity
by: Marta Lavrador, et al.
Published: (2023) -
Anticholinergic burden and most common anticholinergic-acting medicines in older general practice patients
by: Gorup Eva, et al.
Published: (2018) -
Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan
by: Ahmad Al-Azayzih, et al.
Published: (2023) -
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
by: Matera MG, et al.
Published: (2015) -
Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma
by: Francesca Santamaria, et al.
Published: (2022)